2019 Direct-to-Patient Clinical Trials
Aug 8Aug 9, 2019Philadelphia, PA
As industry moves towards a more patient-centric approach, the direct-to-patient clinical trial model stands out as a natural next step in the realm of trial innovation. Despite the benefits for both patients and sponsors, adoption of the siteless/DtP/virtual/remote model presents a novel set of challenges that must be triumphed relating to trial operationalization, protocol development, technology use, supply management and regulatory compliance. CBI’s 2nd Annual Direct-to-Patient Clinical Trials provides a unique opportunity to collaborate with industry pioneers through a mix of real-world examples, interactive discussions and engaging panels to navigate this emerging landscape and successfully enable direct-to-patient trials.